Gilead Sciences Publishes 2023 ESG Impact Report
Gilead Sciences Publishes 2023 ESG Impact Report
NORTHAMPTON, MA / ACCESSWIRE / April 18, 2024 / Gilead Sciences published its 2023 Environmental, Social and Governance (ESG) Impact Report, which uses the ESG framework to highlight the successes and achievements of the prior year.
马萨诸塞州北安普敦/ACCESSWIRE/2024年4月18日/吉利德科学发布了2023年环境、社会和治理（ESG）影响报告，该报告使用ESG框架重点介绍了前一年的成功和成就。
In this year's report, you will see examples of Gilead's impact across four pillars:
在今年的报告中，您将看到吉利德对四大支柱的影响的示例：
- Innovating Scientific Solutions
- Advancing Health Equity and Access
- Empowering People and Communities
- Sustaining Our Shared Planet
- 创新科学解决方案
- 促进健康公平和可及性
- 赋予人们和社区权力
- 维护我们共同的星球
Learn how we're advancing our vision to create a healthier world while benefiting our people, the communities we support and our planet.
了解我们如何推进愿景，创造一个更健康的世界，同时造福我们的人民、我们支持的社区和我们的地球。
Gilead Sciences
吉利德科学
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Gilead Sciences, Inc. 是一家以研究为基础的生物制药公司，在医疗需求未得到满足的领域发现、开发和商业化创新药物。该公司致力于改变和简化对世界各地患有危及生命的疾病患者的护理。吉利德在全球超过35个国家开展业务，总部位于加利福尼亚州福斯特城。
View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.
在 3blmedia.com 上查看吉利德科学提供的更多多媒体和更多 ESG 故事。
Contact Info:
Spokesperson: Gilead Sciences
联系信息：
发言人：吉利德科学
SOURCE: Gilead Sciences
来源：吉利德科学
译文内容由第三方软件翻译。